| Tks5 and SHIP2 regulate invadopodium maturation, but not initiation, in breast carcinoma cells VP Sharma, R Eddy, D Entenberg, M Kai, FB Gertler, J Condeelis Current Biology 23 (21), 2079-2089, 2013 | 196 | 2013 |
| Expression and Imprinting Status of Human PEG8/IGF2AS, a Paternally Expressed Antisense Transcript from the IGF2 Locus, in Wilms' Tumors T Okutsu, Y Kuroiwa, F Kagitani, M Kai, K Aisaka, O Tsutsumi, Y Kaneko, ... The journal of biochemistry 127 (3), 475-483, 2000 | 93 | 2000 |
| Agonist antibody to human thrombopoietin receptor M Kai, K Motoki, S Kataoka, H Yoshida, T Hagiwara US Patent 8,048,421, 2011 | 48 | 2011 |
| Switching constant domains enhances agonist activities of antibodies to a thrombopoietin receptor M Kai, K Motoki, H Yoshida, C Emuta, Y Chisaka, K Tsuruhata, C Endo, ... Nature Biotechnology 26 (2), 209-211, 2008 | 48 | 2008 |
| Estrogen agonists, 17β-estradiol, bisphenol A, and diethylstilbestrol, decrease cortactin expression in the mouse testis R Anahara, M Yoshida, Y Toyama, M Maekawa, M Kai, F Ishino, ... Archives of histology and cytology 69 (2), 101-107, 2006 | 35 | 2006 |
| The Novel Dominant Mutation Dspd Leads to a Severe Spermiogenesis Defect in Mice M Kai, M Irie, T Okutsu, K Inoue, N Ogonuki, H Miki, M Yokoyama, ... Biology of reproduction 70 (4), 1213-1221, 2004 | 30 | 2004 |
| Flutamide depresses expression of cortactin in the ectoplasmic specialization between the Sertoli cells and spermatids in the mouse testis R Anahara, Y Toyama, M Maekawa, M Kai, F Ishino, K Toshimori, C Mori Food and chemical toxicology 44 (7), 1050-1056, 2006 | 29 | 2006 |
| Disruption of CCR1-mediated myeloid cell accumulation suppresses colorectal cancer progression in mice Y Kiyasu, K Kawada, H Hirai, R Ogawa, K Hanada, H Masui, G Nishikawa, ... Cancer letters 487, 53-62, 2020 | 16 | 2020 |
| Anti-estrogen ICI 182.780 and anti-androgen flutamide induce tyrosine phosphorylation of cortactin in the ectoplasmic specialization between the Sertoli cell and spermatids in … R Anahara, Y Toyama, M Maekawa, M Yoshida, M Kai, F Ishino, ... Biochemical and biophysical research communications 346 (1), 276-280, 2006 | 15 | 2006 |
| An antibody-drug conjugate that selectively targets human monocyte progenitors for anti-cancer therapy Y Izumi, M Kanayama, Z Shen, M Kai, S Kawamura, M Akiyama, ... Frontiers in Immunology 12, 618081, 2021 | 12 | 2021 |
| Domain subclass conversion improved activity of anti-Mpl agonist antibodies in the form of whole IgG. M Kai, K Motoki, H Yoshida, K Tsuruhata, C Endo, M Muto, C Emuta, ... Blood, The Journal of the American Society of Hematology 108 (11), 1134-1134, 2006 | 12 | 2006 |
| Agonist antibody to human thrombopoietin receptor M Kai, K Motoki, S Kataoka, H Yoshida, T Hagiwara US Patent 8,236,314, 2012 | 10 | 2012 |
| In vivo efficacy of anti-MPL agonist antibody in promoting primary human hematopoietic cells M Kai, T Hagiwara, C Emuta, Y Chisaka, K Tsuruhata, C Endo, Y Inagaki, ... Blood, The Journal of the American Society of Hematology 113 (10), 2213-2216, 2009 | 3 | 2009 |
| Anti-human CCR1 monoclonal antibody M Kai, S Ogawa, M Taketo, K Kawada, H Hirai, Y Sakai, T Maekawa US Patent 11,912,775, 2024 | | 2024 |
| Anti-human ccr1 monoclonal antibody M Kai, S Ogawa, M Taketo, K Kawada, H Hirai, Y Sakai, T Maekawa US Patent App. 18/459,844, 2024 | | 2024 |
| BISPECIFIC ANTIBODIES CAPABLE OF BINDING TO CD40 AND GPC3 Y SUMITOMO, M Kai | | 2023 |
| TRANSFERRIN RECEPTOR (TFR) BISPECIFIC ANTIBODY K Mitamura, R Nakano, M Kai, N Takahashi | | 2022 |
| Bispecific antibody binding to cd40 and gpc3 Y Sumitomo, M Kai US Patent App. 17/611,344, 2022 | | 2022 |
| BISPECIFIC ANTIBODY BINDING TO TfR K Mitamura, R Nakano, M Kai, N Takahashi US Patent App. 17/418,447, 2022 | | 2022 |
| Anticorpo biespecífico de ligação ao tfr K MITAMURA, R Nakano, M Kai, N Takahashi | | 2021 |
